Why Murray Cod Australia is drawing attention

Murray Cod Australia Limited (ASX: MCA) sits at an inflection point that neatly captures the promise and the peril of small-cap aquaculture. The Riverina-based company has spent years and considerable capital building biomass of its premium Aquna Sustainable Murray cod. In 2026 the story has shifted from growing fish to selling them and, critically, to turning that inventory into cash. A fully underwritten equity raise in May 2026 put that transition front and centre.

This remains a genuinely small, pre-profitability business in operational terms, and the figures below should be read with that stage in mind.

 

Company overview and business model

Murray Cod Australia is a vertically integrated grower of Murray cod, marketed under the Aquna brand as a premium, sustainably farmed native fish. Operations are concentrated around Griffith and the broader Riverina region of New South Wales, spanning hatchery, grow-out ponds and processing. The company positions Aquna as a luxury protein aimed at high-end domestic foodservice and retail, alongside a deliberate push into Asian export markets where Murray cod carries cultural cachet.

The commercial logic is straightforward: grow a differentiated, high-value species at scale, then capture premium pricing across restaurants, retailers such as Woolworths, and export channels spanning Singapore, Hong Kong and other South-East Asian markets, with Middle East opportunities opened by Halal certification.

 

Latest developments

The defining recent event was the May 2026 capital raising. Murray Cod Australia launched a 1-for-1, fully underwritten accelerated non-renounceable entitlement offer priced at $0.15 per share, raising roughly $18.6 million gross, of which about $10.1 million came from the institutional component. The company earmarked the bulk of proceeds, around $15.9 million, for working capital to convert its saleable biomass into cash, with smaller allocations to processing capacity, restructuring and offer costs. Regal Funds Management and chair Brett Paton committed as sub-underwriters.

That use of funds is telling. It confirms the central challenge is no longer biological growth but cash conversion, and the raise was substantially dilutive for holders who did not participate.

Operationally, momentum has been evident. In the March 2026 quarter (Q3 FY26), the company reported grow-out biomass of about 3,700 tonnes, up 32.7% from December 2025, comprising roughly 3.77 million fish at an average weight near 1.0kg. Quarterly sales reached 149.8 tonnes, up 48% year on year, with processed sales up 77.8% to 134.1 tonnes. Exports, while small in absolute terms, jumped 369% to 7.8 tonnes, still only around 7% of quarterly volume.

 

Financial and operational performance

Investors need to separate three very different measures. For the full 2025 financial year (FY25), Murray Cod Australia reported net profit after tax of about $8.6 million. However, that result was driven in large part by biological asset revaluations rather than realised earnings, reflecting the non-cash fair-value uplift on maturing fish rather than trading profit.

The distinction is clearest in the half-year to 31 December 2024 (H1 FY25), where revenue was $4.77 million, up about 4% year on year, while biological asset fair-value gains contributed a far larger $17.23 million. Reported NPAT for that half was $1.33 million, a swing from a prior-year loss. In other words, accounting profit has leaned heavily on the growing value of unsold inventory rather than sales.

 

Balance sheet and cash

Cash is where the pressure shows. In the March 2026 quarter the company recorded customer receipts of $3.46 million, up 32% year on year, but used $8.72 million in operating activities. It ended the quarter with roughly $280,000 in the bank against an overdraft of about $9.9 million, a net position of around negative $9.6 million, per the Appendix 4C.

That backdrop explains both the December 2024 $43 million Westpac facility and the May 2026 equity raise. The company has funded a long biomass build-up that only now is being monetised, and the balance sheet remains a key watch item.

 

The premium-seafood backdrop

Structurally, the thesis has support. Global demand for premium, traceable, sustainably farmed seafood continues to grow, and Murray cod’s white, delicately flavoured flesh commands strong pricing in Asian fine-dining. As a native species farmed domestically, Aquna sidesteps some of the wild-catch and sustainability concerns dogging other proteins. But aquaculture is capital-intensive, biologically risky and exposed to feed costs and water management, and premium positioning limits volume.

 

Growth drivers and catalysts

Forward-looking items to monitor (and these are indicative, not guaranteed) include the pace of processed-sales growth, expansion of the Woolworths footprint reported to have roughly doubled to 134 stores, the ramp in export volumes across Asia and the Middle East, and progress toward full pond utilisation, which management has framed as capacity approaching 4,000 tonnes. Any move to genuinely cash-positive operations would be the most meaningful catalyst.

 

Risks

The risks are material and stage-appropriate. Chief among them: continued negative operating cash flow and reliance on debt and equity funding, with the recent raise heavily dilutive; profit that has depended on non-cash biological revaluations; concentration in a single, premium species; execution risk in scaling sales and exports; and biological, weather and input-cost exposure. Trading liquidity is thin and the shares are volatile.

 

Balanced takeaway

Murray Cod Australia has done the hard, unglamorous work of building biomass and a credible premium brand in Aquna, and the FY26 sales trajectory shows the demand side responding. The unresolved question is financial rather than biological: can the company convert thousands of tonnes of fish into durable, self-funding cash flow before further dilution is required? Until operating cash flow turns, the investment case rests on execution, not accounting gains. This article is information only and not financial advice.